Publications
Endothelial Cells Activated by Tumor Lysis Syndrome and AKI: Beyond Crystal MechanismsHistones Promote Foxp3+ Suppressive Treg Cells In Vitro
Endothelium, Inflammation & Allogenicity, J Am Soc Nephrol. May 6, 2022
Endothelial Cells Activated by Extracellular Histones Promote Foxp3+ Suppressive Treg Cells In Vitro
Endothelium, Inflammation & Allogenicity, eBioMedicine Apr 20, 2022
PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity
Human Systems Immunology & Inflammatory Networks, Nature Communications Apr 13, 2022
CpG-Activated Regulatory B-Cell Progenitors Alleviate Murine Graft-Versus-Host-Disease
Immune responses in the immunocompromised host, Front Immunol Apr 11, 2022
Urinary metabolites give new clues to kidney transplant tolerance
Endothelium, Inflammation & Allogenicity, eBioMedicine Mar 12, 2022
The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.
Lymphocyte development and lymphoid disorders, EMBO Mol Med. Mar 7, 2022
Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection
Endothelium, Inflammation & Allogenicity, Trends Mol Med. Mar 1, 2022
Endothelial cells: major players in acute myeloid leukaemia
Endothelium, Inflammation & Allogenicity, Blood Feb 2, 2022
Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation
Endothelium, Inflammation & Allogenicity, Kidney Int. Jan 26, 2022